Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 6Neoplasms, Plasma Cell 3Pneumonia, Pneumococcal 1Pneumococcal Infections 1Infections 1Febrile Neutropenia 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 7Ciprofloxacin 5gamma-Globulins 3Amoxicillin-Potassium Clavulanate Combination 3liposomal amphotericin B 2Trimethoprim 2Sulfamethoxazole 2Peripheral Blood Stem Cell Transplantation 2Pentetic Acid 2Moxifloxacin 2Melphalan 2Itraconazole 2Immunoglobulins, Intravenous 2Cyclophosphamide 2Caspofungin 2talquetamab 1idecabtagene vicleucel 1fludarabine phosphate 1ethanolamine oleate 1amphotericin B, deoxycholate drug combination 1Whole-Body Irradiation 1Watchful Waiting 1Voriconazole 1Vancomycin 1Valacyclovir 1Therapeutics 1Tazobactam 1Tacrolimus 1Sodium Chloride 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infections × Pneumococcal Vaccines × Plasma cell × Clear all
NCT00046852 2019-11-04

Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma

University of Maryland, Baltimore

Phase 1/2 Completed
Plasma cell

Infections, Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡